352 related articles for article (PubMed ID: 12037142)
1. International Union of Pharmacology. XXXIV. Lysophospholipid receptor nomenclature.
Chun J; Goetzl EJ; Hla T; Igarashi Y; Lynch KR; Moolenaar W; Pyne S; Tigyi G
Pharmacol Rev; 2002 Jun; 54(2):265-9. PubMed ID: 12037142
[TBL] [Abstract][Full Text] [Related]
2. Subtype-specific, differential activities of the EDG family receptors for sphingosine-1-phosphate, a novel lysophospholipid mediator.
Takuwa Y; Okamoto H; Takuwa N; Gonda K; Sugimoto N; Sakurada S
Mol Cell Endocrinol; 2001 May; 177(1-2):3-11. PubMed ID: 11377814
[TBL] [Abstract][Full Text] [Related]
3. The Edg family G protein-coupled receptors for lysophospholipids: their signaling properties and biological activities.
Takuwa Y; Takuwa N; Sugimoto N
J Biochem; 2002 Jun; 131(6):767-71. PubMed ID: 12038970
[TBL] [Abstract][Full Text] [Related]
4. Lysophosphatidic acid and sphingosine 1-phosphate protection of T cells from apoptosis in association with suppression of Bax.
Goetzl EJ; Kong Y; Mei B
J Immunol; 1999 Feb; 162(4):2049-56. PubMed ID: 9973477
[TBL] [Abstract][Full Text] [Related]
5. Molecular identification and characterization of G protein-coupled receptors for lysophosphatidic acid and sphingosine 1-phosphate.
An S
Ann N Y Acad Sci; 2000 Apr; 905():25-33. PubMed ID: 10818439
[TBL] [Abstract][Full Text] [Related]
6. Sphingosine 1-phosphate signalling through the G-protein-coupled receptor Edg-1.
Zondag GC; Postma FR; Etten IV; Verlaan I; Moolenaar WH
Biochem J; 1998 Mar; 330 ( Pt 2)(Pt 2):605-9. PubMed ID: 9480864
[TBL] [Abstract][Full Text] [Related]
7. International Union of Basic and Clinical Pharmacology. LXXVIII. Lysophospholipid receptor nomenclature.
Chun J; Hla T; Lynch KR; Spiegel S; Moolenaar WH
Pharmacol Rev; 2010 Dec; 62(4):579-87. PubMed ID: 21079037
[TBL] [Abstract][Full Text] [Related]
8. Biochemical regulation of breast cancer cell expression of S1P2 (Edg-5) and S1P3 (Edg-3) G protein-coupled receptors for sphingosine 1-phosphate.
Dolezalova H; Shankar G; Huang MC; Bikle DD; Goetzl EJ
J Cell Biochem; 2003 Mar; 88(4):732-43. PubMed ID: 12577307
[TBL] [Abstract][Full Text] [Related]
9. A growing family of receptor genes for lysophosphatidic acid (LPA) and other lysophospholipids (LPs).
Chun J; Contos JJ; Munroe D
Cell Biochem Biophys; 1999; 30(2):213-42. PubMed ID: 10356643
[TBL] [Abstract][Full Text] [Related]
10. Dual mechanisms for lysophospholipid induction of proliferation of human breast carcinoma cells.
Goetzl EJ; Dolezalova H; Kong Y; Zeng L
Cancer Res; 1999 Sep; 59(18):4732-7. PubMed ID: 10493533
[TBL] [Abstract][Full Text] [Related]
11. Sphingosine-1-phosphate, a platelet-derived lysophospholipid mediator, negatively regulates cellular Rac activity and cell migration in vascular smooth muscle cells.
Ryu Y; Takuwa N; Sugimoto N; Sakurada S; Usui S; Okamoto H; Matsui O; Takuwa Y
Circ Res; 2002 Feb; 90(3):325-32. PubMed ID: 11861422
[TBL] [Abstract][Full Text] [Related]
12. Lysophospholipid receptors in the nervous system.
Toman RE; Spiegel S
Neurochem Res; 2002 Aug; 27(7-8):619-27. PubMed ID: 12374197
[TBL] [Abstract][Full Text] [Related]
13. EDG receptors and hepatic pathophysiology of LPA and S1P: EDG-ology of liver injury.
Svetlov SI; Sautin YY; Crawford JM
Biochim Biophys Acta; 2002 May; 1582(1-3):251-6. PubMed ID: 12069835
[TBL] [Abstract][Full Text] [Related]
14. Edg-6 as a putative sphingosine 1-phosphate receptor coupling to Ca(2+) signaling pathway.
Yamazaki Y; Kon J; Sato K; Tomura H; Sato M; Yoneya T; Okazaki H; Okajima F; Ohta H
Biochem Biophys Res Commun; 2000 Feb; 268(2):583-9. PubMed ID: 10679247
[TBL] [Abstract][Full Text] [Related]
15. Signaling mechanisms and molecular characteristics of G protein-coupled receptors for lysophosphatidic acid and sphingosine 1-phosphate.
An S; Goetzl EJ; Lee H
J Cell Biochem Suppl; 1998; 30-31():147-57. PubMed ID: 9893266
[TBL] [Abstract][Full Text] [Related]
16. Bioactive lysophospholipids and their G protein-coupled receptors.
Moolenaar WH
Exp Cell Res; 1999 Nov; 253(1):230-8. PubMed ID: 10579925
[TBL] [Abstract][Full Text] [Related]
17. Lysophospholipid receptors: signalling, pharmacology and regulation by lysophospholipid metabolism.
Meyer zu Heringdorf D; Jakobs KH
Biochim Biophys Acta; 2007 Apr; 1768(4):923-40. PubMed ID: 17078925
[TBL] [Abstract][Full Text] [Related]
18. Ras-MAP kinase signaling by lysophosphatidic acid and other G protein-coupled receptor agonists.
Kranenburg O; Moolenaar WH
Oncogene; 2001 Mar; 20(13):1540-6. PubMed ID: 11313900
[TBL] [Abstract][Full Text] [Related]
19. Expression of the lysophospholipid receptor family and investigation of lysophospholipid-mediated responses in human macrophages.
Duong CQ; Bared SM; Abu-Khader A; Buechler C; Schmitz A; Schmitz G
Biochim Biophys Acta; 2004 Jun; 1682(1-3):112-9. PubMed ID: 15158762
[TBL] [Abstract][Full Text] [Related]
20. Lysophospholipid enhancement of human T cell sensitivity to diphtheria toxin by increased expression of heparin-binding epidermal growth factor.
Goetzl EJ; Kong Y; Kenney JS
Proc Assoc Am Physicians; 1999; 111(3):259-69. PubMed ID: 10354366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
